Predictive value of ex-vivo drug-inhibited cytokine production for clinical response to biologic DMARD therapy in rheumatoid arthritis.

CONCLUSIONS: Ex-vivo inhibition of cytokine production by bDMARDs is unable to help prediction of treatment response to bDMARDs in RA. PMID: 30767874 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30767874?dopt=Abstract

Source: Clinical and Experimental Rheumatology - February 17, 2019 Category: Rheumatology Tags: Clin Exp Rheumatol Source Type: research